CAPcasts

In this episode of CIPI Connections, Jordan Olson, MD, FCAP, and Meredith Herman, DO, share practical insights and lessons learned from real-world digital pathology adoption. They also discuss the new Digital Pathology 101 Guide, created by the CAP's Digital & Computational Pathology Committee.Download the Digital Pathology 101 Guide: https://www.cap.org/member-resources/councils-committees/digital-pathology-topic-centerSubscribe to CIPI Connections on Apple Podcasts, Spotify, or wherever you listen to podcasts.

In this episode, academic pathologist Edward Gutmann, MD, FCAP, speaks with Dean Joelson, MD, FCAP, a solo practitioner, about what it is like to practice pathology solo in a semi-rural area. They discuss the preparation needed to establish such a practice, the challenges and rewards of serving a community hospital alone, and how these experiences differ from group and academic settings. Surprisingly, and for different reasons, both guests reject the long-held notion that pathologists are "the doctor’s doctor." A byproduct of a chance encounter at the CAP's annual meeting, the conversation begins and ends with how the CAP supports pathologists across diverse practice environments.

In this episode of CIPI Connections, members of the CAP Informatics Committee, Alexis Carter, MD, FCAP, and Lauren Miller, MD, MLS(ASCP)cm, share a cautionary tale about how when it comes to point-of-care testing, sharing is not always caring.Informatics CommitteeCouncil on Informatics and Pathology Innovation (CIPI)For questions, feedback or to learn how to submit your own idea, please email [email protected]. Subscribe to CIPI Connections on Apple Podcasts, Spotify, or wherever you listen to podcasts.

In this episode of CIPI Connections, Nicholas Reder, MD, MPH, FCAP, joins M. E. de Baca, MD, FCAP, to discuss the shift from traditional 2D slides to whole tissue imaging, the expanding role of artificial intelligence in pathology, and the responsibility that innovators carry as medicine and technology evolve.Council on Informatics and Pathology InnovationSubscribe to CIPI Connections on Apple Podcasts, Spotify, or wherever you listen to podcasts.For questions or feedback, please email Viral Mehta at [email protected].

Hear from expert panel chairs on the new CAP evidence-based guideline on the workup of amyloidosis. Dylan Miller, MD, FCAP, and Billie Fyfe-Kirschner, MD, FCAP, discuss recommendations for staining techniques and share why fibril subtyping is critical for patient outcomes.CAP Guideline: Laboratory Workup of Amyloidosis

In this episode of CIPI Connections, members of the CAP Informatics Committee, Alexis Carter, MD, FCAP, and Omar Baba, MD, share a gripping cautionary tale of unflagged abnormal laboratory values and the informatics solutions designed to avert similar pitfalls. Informatics CommitteeCouncil on Informatics and Pathology Innovation (CIPI)Subscribe to CIPI Connections on Apple Podcasts, Spotify, or wherever you listen to podcasts.

In this episode of CIPI Connections, members of the CAP Artificial Intelligence Committee, Matthew Hanna, MD, FCAP, Nick Spies, MD, FCAP, and Larissa Furtado, MD, FCAP, discuss how pathology is integrating AI. They discuss how existing CAP validation frameworks apply to AI, the unique challenges of data quality and, and the emerging role of AI implementation specialists. Hear real-world insights from anatomic, clinical, and molecular pathology on what works, what doesn’t, and how AI can enhance patient safety.AI CommitteeCouncil on Informatics and Pathology Innovation (CIPI)Subscribe to CIPI Connections on Apple Podcasts, Spotify, or wherever you listen to podcasts.

As the founder of PathPresenter, a groundbreaking global platform with over 70,000 users, Rajendra Singh, MD, FCAP mission is clear: to make whole slide images accessible for educational purposes. His passion for pathology has driven him to integrate advanced technology into everyday practice, ensuring that pathologists remain at the forefront of health care innovation.Learn more about PathPresenterVisit the Innovation Hub at CAP25 in Orlando, FloridaSubscribe to CIPI Connections on Apple Podcasts, Spotify, or wherever you listen to podcasts.

Welcome to the debut episode of CIPI Connections, the official podcast of the College of American Pathologists' Council on Informatics and Pathology Innovation (CIPI). Co-hosts Dr. Giovanni Lujan and Dr. M.E. de Baca introduce the podcast’s mission and discuss Dr. de Baca’s inspiring journey from ophthalmology in Germany to leading innovation in pathology.Learn how CIPI and its five committees are shaping the future of digital pathology, AI, cancer reporting, and more—and what listeners can expect from future episodes.Subscribe to CIPI Connections on Apple Podcasts, Spotify, or wherever you listen to podcasts.

PATH News Network Daily Edition is the College of American Pathologists' flagship daily newscast, providing the most up-to-the-minute news and information about pathology and laboratory medicine.Tune in weekdays at 5:00 AM Eastern Time starting July 14th. Available wherever you get your podcasts, including:Apple PodcastsAmazon MusicOvercastSpotifyYouTube

When pathologists go to advocate for causes that are important to the specialty, having a uniform approach is key to getting the message across. Tevi Troy, CEO of the American Health Policy Institute and former US Deputy Secretary of Health and Human Services, says having a unilateral approach to what you're trying to lobby for is the key to success in advocacy.Listen to Troy discuss how pathologists can come together to advocate.Tevi Troy BiographyHouse of Delegates and Pathologists Leadership Summit

With slides and a Substack, Bruce Mehlman, Partner at Mehlman Consulting and former Assistant Secretary of Commerce, works to help people understand the state of our political system, how we got here, and future concerns.Mehlman encourages pathologists to remain engaged by embracing patience, persistence, and making personal connections with lawmakers. Mehlman shares his advice with 25 HODPLS attendees and encourages them to advance pathology through education and advocacy. Bruce Mehlman BiographyBruce Mehlman SubstackHouse of Delegates and Pathologists Leadership SummitPathPAC

Alfred Wray Campbell, MD, MBA, FCAP, is secretary-treasurer of the CAP Board of Governors. He offers an overview of the CAP's financial reports.CAP Annual Report 2024

This weekend, pathologists in Washington, DC for the CAP's House of Delegates and Pathologists Leadership Summit can attend a new strategic leadership workshop. The event is designed to help CAP members build credibility, influence, and authority.In this podcast episode, Carey August, MD, FCAP, gives members a preview of the free executive leadership workshop happening this Saturday, April 26, in Washington, DC.American College of Healthcare ExecutivesCAP EducationCAP Education Course ProposalsCollege of American Pathologists: Engaged Leadership Academy 2025Engaged Leadership AcademyHouse of Delegates and Pathologists Leadership SummitPathology on the CoastHow to add the workshop to your existing registrationJoin us for a new day-long workshop, Increase Your Influence Through Strategic Leadership, co-developed by CAP members along with faculty from the American College of Healthcare Executives (ACHE). It's open to all attendees at no extra charge.The course builds on communication skills developed through the CAP's Engaged Leadership Academy (ELA)—without duplicating ELA materials or requiring previous enrollment in the program.If you want to attend, please select Begin Member Registration to edit your existing registration, log in, and follow these steps:Click the "+Leadership Workshop and Food Functions" boxClick "Next" to confirm attendance at the House of Delegates & Pathologists Leadership SummitAdd the "New Leadership Workshop" by clicking the plus button on the right

The CAP's political action committee, PathPAC, provides its members with a collective voice on issues important to the specialty and patients. PathPAC is the only federal political action committee working on behalf of pathology and pathologists. It was created to advocate for the election and re-election of candidates for federal office who understand the value of pathology in improving diagnostic patient care. E. Randy Eckert, MD, FCAP, Chair of the CAP's Political Action Committee (PathPAC), shares how personal contributions support PathPAC's mission.    CAP Political Action Committee (PathPAC)Council on Government and Professional AffairsHouse of Delegates and Pathologists Leadership SummitLobbying and Political ActionPathNET  Political Education Fund 

As a pathologist, you know how to advocate, but do you have plans to let Congress know where you stand? Now is your chance to make your voice heard on Medicare payment reform, workforce concerns, and other critical pay-related policies.Come to Washington, DC for the CAP's House of Delegates and Pathologists Leadership Summit from April 26 through April 29.Diana M. Cardona, MD, MBA, FCAP, Vice Chair of the Council on Government and Professional Affairs and a member of the CAP's Board of Governors, explains why it's important for pathologists to attend the summit and join their colleagues on Capitol Hill later this month.Advocacy at the CAPCouncil on Government and Professional AffairsHouse of Delegates and Pathologists Leadership SummitLobbying and Political ActionMedicare Coverage AdvocacyPathPACPayments for Pathology Services

A new workshop to help pathologists grow their influence through strategic leadership is on the agenda when members of the College of American Pathologists meet in Washington, DC, this month.The CAP is partnering with the American College of Healthcare Executives to produce the workshop. It offers six CME hours to attendees. The workshop is planned for Saturday, April 26, the first day of the House of Delegates and Pathologists Leadership Summit April 26–29.Jim Austin, faculty consultant for the Wharton School at the University of Pennsylvania and adjunct assistant professor at Brown University, facilitates the new workshop to help pathologists grow their influence.American College of Healthcare ExecutivesCAP EducationHouse of Delegates and Pathologists Leadership SummitJim Austin's BiographyHow to add the workshop to your existing registrationJoin us for a new day-long workshop, Increase Your Influence Through Strategic Leadership, co-developed by CAP members along with faculty from the American College of Healthcare Executives (ACHE). It's open to all attendees at no extra charge.The course builds on communication skills developed through the CAP's Engaged Leadership Academy (ELA)—without duplicating ELA materials or requiring previous enrollment in the program.If you want to attend, please select Begin Member Registration to edit your existing registration, log in, and follow these steps:Click the "+Leadership Workshop and Food Functions" boxClick "Next" to confirm attendance at the House of Delegates & Pathologists Leadership SummitAdd the "New Leadership Workshop" by clicking the plus button on the right

Four key policy issues will top the list of priorities the CAP will raise when members go to Capitol Hill on April 29.  If you're concerned about the impact of federal policy on you and your patients, then you need to make time to be among those who visit the nation’s capital April 26–29. Mary Le, MD, FCAP, Chair of the CAP's Federal and State Affairs Committee, previews the CAP's federal policy agenda.AdvocacyFederal and State Affairs CommitteeHouse of Delegates and Pathologists Leadership SummitLaboratory-Developed Test OversightLobbying and Political ActionMedicare Coverage AdvocacyPathPACPayments for Pathology Services

Congress hasn't been able to agree on inflationary pay increases for pathologists.  During the College of American Pathologists annual House of Delegates/Pathologists Leadership Summit, members will let Congress know where they stand on Medicare payments and other issues affecting pathologists and patients. The more pathologists who join the CAP on Capitol Hill, the better we can advocate for pathology.A. Joe Saad, MD, CPE, FCAP, Chair of the CAP's Council on Government and Professional Affairs, discusses why members should attend and prepare for the CAP's premier advocacy and leadership event in April. 2025 Fall House of Delegates Meeting at CAP25Advocacy at the CAPCAP PathNET Action Alert CenterCAP Shares Priorities with New CongressCouncil on Government and Professional AffairsHouse of DelegatesHOD/Pathologists Leadership SummitLaboratory-Developed Test OversightPathPAC 

Pathologists from across the US will gather in Washington, DC, in April to discuss important policy issues impacting their practice and patients.It's all a part of the College of American Pathologists annual House of Delegates and Pathologists Leadership Summit happening April 26–29. Sang Wu, MD, FCAP, speaker of the CAP House of Delegates, says delegates are ready to make their voices heard at this year's summit. Listen to the episode.Advocacy at the CAPHouse of DelegatesHouse of Delegates Steering CommitteeHOD/Pathologists Leadership Summit PathPACPathNET

Understanding new digital technologies and helping members engage with them in their laboratories are at the top of the informatics and innovation agenda at the College of American Pathologists. M. E. (Doc) de Baca, MD, FCAP, Chair of the CAP's Council on Informatics and Pathology Innovation and a member of the CAP's Board of Governors, discusses the Council’s accomplishments in 2024 and priorities in 2025.CAP Annual Meeting 2025CAP PodcastsCouncils and CommitteesCouncil on Informatics and Pathology InnovationEmerging News and EventsHouse of Delegates/Pathologists Leadership SummitLessons Learned: Successful Adoption of Digital Pathology Webinar

Cutting edge training, education about new policies, and programs to develop future pathologists are all at the top of the education agenda at the College of American Pathologists. Kalisha Hill, MD, MBA, FCAP, FASCP, Chair of the CAP's Council on Education and a member of the CAP's Board of Governors discusses the educational wins in 2024 and Council priorities for 2025.CAP Education CAP Education Course Proposals Clinical Pathology Improvement Program (CPIP) Council on Education Future Pathologist ChampionsLab Professional Programs Laboratory-Developed Tests Oversight Pathology on the Coast

This year marks the beginning of a new membership era at the College of American Pathologists, focusing on several priorities, including member recruitment, onboarding and retention, creating a personalized member experience, and facilitating networking and mentoring.Guillermo Martinez-Torres, MD, FCAP, Chair of the Council on Membership and Professional Development, and a member of the CAP's Board of Governors, discusses successes in 2024 and Council priorities for the new year.Be a Part of a CAP Laboratory Inspection TeamCouncil on Membership and Professional DevelopmentCommittee ApplicationsEngaged Leadership AcademyHouse of DelegatesHouse of Delegates & Pathologists Leadership SummitMember BenefitsMember ResourcesPathology Careers

Hundreds of new laboratories achieving accreditation, releasing new checklists, and increasing communication with international partners are at the top of the accreditation agenda at the College of American Pathologists.Earle S. Collum, MD, FCAP, Chair of the CAP's Council on Accreditation, discusses the CAP's recent accreditation accomplishments and gives a preview of accreditation priorities for 2025. Biorepository Accreditation Program CommitteeCouncil on Accreditation CAP Laboratory Accreditation CAP 15189 Accreditation Program Proficiency TestingLaboratories Outside the USALaboratory Accreditation Program

Pathologists have an opportunity to make their voice heard on key policy issues under consideration in Congress. The College of American Pathologists will host its annual House of Delegates and Pathologists Leadership Summit April 26 –29 in Washington, DC. Listen to CAP President Donald Karcher, MD, FCAP, share why pathologists should attend the annual summit and his experience advocating for pathologists and patients on Capitol Hill. House of Delegates & Pathologists Leadership Summit 2025 CAP Shares Top 6 Priority Issues with New Congress and Administration for Success in 2025, CAP NewsroomPathNET Action Center PathPAC

Leading the development of new proficiency testing programs for laboratories, the publication of new research, and tracking threats to public health are at the top of the scientific agenda at the College of American Pathologists. In this episode, Council on Scientific Affairs Chair and member of the CAP’s Board of Governors, Bobbi Pritt, MD, MSc, FCAP, highlights the CAP’s scientific accomplishments and priorities.Council on Scientific AffairsCAP Evidence-based GuidelinesHouse of Delegates & Pathologists Leadership Summit 2025Media Briefing: Pathologists Discuss the Bird Flu Outbreak, CAP NewsroomProficiency Testing 75 Years in Proficiency Testing: A Journey of Impact, Partnership, and Limitless Potential

In this episode, Daniel Owens, Vice President of the Royal College of Pathologists of Australasia visits Washington, DC, to learn about the CAP's advocacy work in the nation's capital.Learn more:The Royal College of Pathologists of Australasia

Throughout 2024, the College of American Pathologists (CAP) advocated on behalf of pathologists to address critical issues, including the oversight of laboratory-developed tests (LDTs), protecting the value of pathology services, opposing private payer interference, and state-level regulation of health insurance. The CAP is now ready to engage on these and other important pathology issues during the first 100 days of the Trump Administration and new Congress in 2025. In this special episode, Council on Government and Professional Affairs Chair Joe Saad, MD, CPE, FCAP highlights a year of advocacy legislative wins and 2025 legislative priorities.Advocacy highlights in this episode:CAP President testifies during congressional hearing on LDT oversight, CAP NewsroomCapitol Hill briefing on LDTs, YouTubeLetter to Trump Transition Team about rescinding the LDT final rule (PDF)Letter to Office for Management & Budget opposing the LDT final rule (PDF)Pathologists meet with Congress to oppose Medicare cuts, CAP Advocacy UpdateStudy examining the adverse impact of insurance interference (PDF)Illinois pathologists and CAP secure new network adequacy law, CAP Advocacy Update

In this episode, Gladell Paner, MD, FCAP, hosts a dynamic discussion with experts Alison Van Dyke, MD, PhD, FCAP, Rich Moldwin, MD, and Mary Kay Washington, MD, PhD, FCAP, about Cancer PathCHART—a groundbreaking initiative redefining cancer surveillance standards. Learn how this collaborative effort between the CAP, the National Cancer Institute, and global partners harmonizes terminology and updates tumor site morphology standards. Discover how Cancer PathCHART ensures more accurate data, improves cancer research, and enhances public health—all while supporting pathologists and cancer registrars in their critical roles.

In this deeply personal and insightful CAPcast, Dr. Alison Van Dyke and Dr. Darrell Kirch share their journeys through mental health challenges and discuss the pervasive issue of physician burnout. With a focus on breaking the stigma, they explore the importance of seeking help, fostering open conversations, and building supportive communities. They also highlight systemic changes in medical training and healthcare environments that promote wellness. View the resources mentioned in this episode here. Explore additional wellness resources curated by the CAP's Wellness Project Team.

In this episode, Dr. Juanita Evans interviews Dr. Michael Williams on his journey of building a platform to amplify diverse voices in pathology. Together, they discuss the challenges and triumphs of fostering inclusivity in healthcare, highlighting how representation reshapes patient care, medical education, and the future of medicine.Support the CAP Foundation this giving season to help improve health outcomes and ensure the future of pathology.

Insurer interference is on the rise, creating barriers for patients to access medical care. Insurer interference often happens under the guise of cost-cutting measures for patients, but pathologists report an increase in disruptions to providing timely diagnosis and medical care for their patients. In this CAPcast, we discuss how insurer interference impacts medical treatment with Dr. Theresa Emory, Chair, CAP's Payment Policy Subcommittee.

Dr. Joel Moncur is joined by a panel of distinguished experts to discuss the groundbreaking journey of molecular proficiency testing programs, including next-generation sequencing (NGS). Drs. Wayne Grody, Karl Voelkerding, and Jason Merker discuss the impact these programs have on laboratories, patient care, and regulatory compliance, as well as the role of molecular pathology in shaping the future of health care.This episode is part of a CAPcast series highlighting the CAP’s proficiency testing program, which is celebrating its 75th anniversary in 2024.

In this CAPcast episode, Dr. Gladell Paner speaks with two GI and liver pathologists, Dr. William Chopp and Dr. John Hart, as they explore the use of the CAP hepatocellular carcinoma (HCC) reporting protocol in both academic and private practice settings. Tune in as Dr. Chopp discusses the evolution of HCC reporting standards and how the protocol adapts to new data. Dr. Hart shares insights on synoptic reporting's role in standardizing cancer care and the importance of accurately subtyping HCC to guide clinical decisions. They also delve into molecular testing, multifocality, satellite lesions, and the critical role of pathology in liver transplant assessments.

The perception of pathology as one of medicine's best-kept secrets underscores the growing concern that medical students are not exposed to it early enough. To highlight the specialty's clinical importance, Dr. Swati Bhardwaj recently sat down with CAP members Dr. Valerie Fitzhugh, Dr. Gary Procop, Dr. Bronwyn Bryant, and Dr. Kalisha Hill to talk about current efforts to improve pathology education in U.S. medical schools and address gaps in histology knowledge.

In this CAPcast episode, we discuss the CAP's accuracy-based proficiency testing (PT) programs with experts Dr. David Sacks and Dr. Andy Hoofnagle. Dive into the history and evolution of accuracy-based PT, which uses advanced techniques to ensure lab results meet rigorous national and international standards. Learn how these programs revolutionized hemoglobin A1C testing and explore the future of laboratory accuracy in critical tests like vitamin D and testosterone.This episode is part of a CAPcast series highlighting the CAP’s proficiency testing program, which is celebrating its 75th anniversary in 2024.Learn more and register for the CAP's Job Prep Bootcamp, a fast-paced interactive review of pathology cases across subspecialties, delivered in a virtual format.

Genomic studies center on detecting and excluding single nucleotide variants. While evaluation of structural variants remains most often performed by traditional cytogenetic approaches, these unaddressed blind spots in cytogenetic studies leave room to improve detection of clinically relevant structural variants through other methodologies including optical genome mapping, or OGM. OGM is an imaging technology that evaluates the fluorescent labeling pattern of individual DNA molecules with the resolution far exceeding conventional cytogenetic approaches. In this episode, Dr. Annette Kim, MD, PhD, FCAP, and Dr. Adrian Dubuc, PhD, FCMAG, discuss how optical genome mapping stacks up compared to established methods like FISH and karyotyping, as well as some of its current limitations.Learn more and register for the CAP's Job Prep Bootcamp, a fast-paced interactive review of pathology cases across subspecialties, delivered in a virtual format.

In this episode, members of the CAP's New-in-Practice Committee share valuable advice for effective communication with non-pathology colleagues. Dr. Esther Yoon, Dr. Hafsa Nebbache, and Dr. Jennifer Woo discuss their personal experiences, survey insights, and strategies for building strong relationships with clinicians, handling challenging conversations, and improving patient care through better communication. Tune in for practical tips every new pathologist should know.

The Food and Drug Administration's (FDA) Laboratory Developed Test (LDT) final rule outlines new regulations for tests developed and used within a single laboratory. In this episode, we will discuss the newly proposed rule and the CAP's ongoing advocacy efforts to protect pathologists and ensure patients have access to the tests they need for quality care.

In this CAPcast episode, Gladell Paner, MD, FCAP, discusses the renaming of low-grade prostate cancer with genitourinary pathologists Ming Zhou, MD, FCAP, and Rajal Shah, MD, FCAP. They explore the history, benefits, and challenges of removing the cancer label from Grade Group 1 prostate cancer and its potential impact on patient care, pathologist practices, and the broader healthcare system.

While blood transfusion safeguards are highly effective, they're not completely infallible. If new information arises suggesting an unsuitable blood unit was collected and then unknowingly transfused, the blood bank must undertake a “lookback,” or a process of investigating and identifying prior donations from the same donor. This episode features a discussion on lookbacks between Dr. Alexis Peedin and Dr. Melissa George. Learn more about blood bank lookbacks via Dr. George’s recently authored CPIP case, linked in the Resources section.

Join Gladell Paner, MD, FCAP, as he delves into inherited cancer syndromes with surgical pathologist Vania Nosé, MD, FCAP, and oncologist Mark Lewis, MD, who is also a cancer survivor. They focus on multiple endocrine neoplasia type 1 (MEN1), an autosomal dominant disorder affecting the pituitary, parathyroid, and pancreas. Dr. Nosé explores the genetic and clinical aspects of MEN1, while Dr. Lewis shares his personal journey with the condition. Together, they discuss treatment advancements, tumor prognosis, and how personal stories can raise awareness and ease fears about medical procedures.

Beginning in the early 2000s, the number of US medical school seniors matching into a pathology residency experienced a steady decline. Rates went from 2.5% in 2003 to nearly 1% in the late 2010s. In response, the CAP created the Future Pathologist Initiative Project Team to address the critical issue of preventing a pathologist shortage by inspiring medical students to explore pathology as a career path.This episode features Dr. Kalisha Hill, project team chair, and Dr. Kamran Mirza, future pathologist champion facilitator, to discuss the team’s efforts and accomplishments. In the second half of the episode, they speak to Dr. Carli Cox, a former medical student turned pathology resident, and her mentor, Dr. Murat Gokden, about their experience going through the Future Pathologist Champion Program.Learn more and register for the CAP's Job Prep Bootcamp, a fast-paced interactive review of pathology cases across subspecialties, delivered in a virtual format.

Pathology reports are pathologists’ main line of connection with patients—their primary stakeholders. Since the CURES Act made it so patients can access their pathology reports digitally as soon as they’re released, questions have been raised about how to make the reports more discernable for the average person. However, the pathology report must also speak to the patient’s care team, who use it to determine their treatment. In this episode, Dr. Diana Cardona and Dr. Harry Hwang discuss the feedback and concerns of the various stakeholder groups for pathologists’ reports and explore potential changes to the standard report format that could work for all parties without placing undue burden on pathologists.Learn more and register for the CAP's Job Prep Bootcamp, a fast-paced interactive review of pathology cases across subspecialties, delivered in a virtual format.

In this special edition CAPcast, the College of American Pathologists (CAP) shares the audio of a July 9 briefing on laboratory-developed tests (LDTs). The CAP discussed how Congress can promote patient safety without overburdening laboratories through enacting a diagnostic reform package that provides oversight of LDTs and allows for innovation of new technologies. The Capitol Hill briefing featured top pathologists from around the country who provided background on LDTs and answered questions from congressional staffers. For more than a decade, the CAP has advocated for an LDT regulatory framework that enhances patient safety, maintains access to quality laboratory testing, and promotes innovation without creating significant regulatory burdens on pathologists. Following the May 6 issuance of the Food and Drug Administration (FDA) LDT final regulation, the CAP is greatly concerned that the FDA is moving forward with its regulatory oversight plan for LDTs without making the additional changes needed to ensure both patient safety and access to accurate and innovative testing. CAP President Donald Karcher, MD, FCAP, and Joe Saad, MD, FCAP, President of the Surgical Pathologists of Dallas, spoke with congressional staff about these issues.Overall, they sought to educate Congress about the underlying problems with the FDA rule and encourage legislative action that targets FDA oversight to tests representing the highest risk to patients while leveraging existing structures to maintain quality and access to lower-risk LDTs. The physicians explained what LDTs are and why they are important, the impact of the FDA's diagnostic rule on the provision of LDTs and patient testing, and why the Verifying Accurate Leading-Edge IVCT Development (VALID) Act, not the FDA final rule, provides the necessary oversight to ensure safe, quality laboratory tests for all patients.

Gladell Paner, MD, FCAP, speaks with dermatopathologists Wonwoo Shon, DO, FCAP, and Christopher Kinonen, MD, MBA, FCAP. The group discusses the development of the CAP's new melanoma reporting templates, how they are used in testing, and what's on the horizon for biomarkers.

The CAP introduced its first infectious disease testing survey program in 1989, 40 years after launching its PT survey program in 1949. Over the past 35 years, the CAP has led the way in developing new programs to ensure the quality and accuracy of laboratory testing for infectious diseases, including SARS CoV-2, Zika testing, and testing for molecular microbiology multiplex panels. In this CAPcast episode, Drs. Christine Wojewoda and Daniel Rhoads, Chair and Vice Chair of the CAP’s Microbiology Committee, discuss how the program has evolved over the years, its impact on public health, including the historic COVID-19 pandemic, and what future directions the program is focusing on to ensure that patients continue to receive accurate infectious disease test results. This episode is part of a CAPcast series highlighting the CAP’s proficiency testing program, which is celebrating its 75th anniversary in 2024.

Launched in 2004, the CAP’s Laboratory Preparedness Exercise (LPX) was developed as a collaborative effort involving the College of American Pathologists, the Centers for Disease Control and Prevention, and the Association of Public Health Laboratories. In this CAPcast episode, Dr. Kathleen Beavis and Dr. Carol Rauch discuss the history of the program and its important role in helping laboratories assess and enhance their readiness for emergencies, disasters, and other challenging situations. This episode is part of a series highlighting the CAP’s proficiency testing program, which is celebrating its 75th anniversary in 2024.

The 2024 Pathologists Leadership Summit took place in mid-April and featured the Spring House of Delegates meeting, educational courses, Advocacy programing, and our annual Hill Day. For this episode, we revisit the Pathologists Leadership Summit with two CAP leaders. Dr. Sang Wu is speaker of the CAP’s House of Delegates. And, Dr. Mary Le is the vice chair for the CAP Federal and State Affairs Committee.

Gladell Paner, MD, FCAP, speaks with Raja Seethala, MD, FCAP, and Nicole Cipriani, MD, FCAP, surgical pathologists specializing in head and neck pathology and members of the CAP Cancer Committee. The group discusses the development of the CAP's Head and Neck Biomarker Reporting Templates, how they are used in testing, and what's on the horizon for biomarkers.